In addition, TINAGL1-deficient CAFs did not induce FAK phosphorylation and migration in cancer cells to the same extent as wild-type or negative control siRNA-treated CAFs (Fig. 4B–D, Additional file 1: Fig. S3E). Here, PTK2 is linked to cancer.